Wird geladen …
Nanotherapeutics in transplantation: How do we get to clinical implementation?
Patients undergoing organ transplantation transition from one life‐altering issue (organ dysfunction) to a lifelong commitment—immunosuppression. Regimens of immunosuppressive agents (ISAs) come with significant side effects and comorbidities. Recently, the use of nanoparticles (NPs) as a solution t...
Hauptverfasser: | , , , , , |
---|---|
Format: | Online Artikel Text |
Sprache: | English |
Veröffentlicht: |
John Wiley and Sons Inc.
2022
|
Schlagworte: | |
Online Zugang: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081154/ https://www.ncbi.nlm.nih.gov/pubmed/35224837 http://dx.doi.org/10.1111/ajt.17012 |